Understanding the pharmacological properties of a metabolic PET tracer in prostate cancer Journal Article


Authors: Viola-Villegas, N. T.; Carlin, S. D.; Ackerstaff, E.; Sevak, K. K.; Divilov, V.; Serganova, I.; Kruchevsky, N.; Anderson, M.; Blasberg, R. G.; Andreev, O. A.; Engelman, D. M.; Koutcher, J. A.; Reshetnyak, Y. K.; Lewis, J. S.
Article Title: Understanding the pharmacological properties of a metabolic PET tracer in prostate cancer
Abstract: Generally, solid tumors (>400 mm3) are inherently acidic, with more aggressive growth producing greater acidity. If the acidity could be targeted as a biomarker, it would provide a means to gauge the pace of tumor growth and degree of invasiveness, as well as providing a basis for predicting responses to pH-dependent chemotherapies. We have developed a 64Cu pH (low) insertion peptide (pHLIP) for targeting, imaging, and quantifying acidic tumors by PET, and our findings reveal utility in assessing prostate tumors. The new pHLIP version limits indiscriminate healthy tissue binding, and we demonstrate its targeting of extracellular acidification in three different prostate cancer models, each with different vascularization and acid-extruding protein carbonic anhydrase IX (CAIX) expression. We then describe the tumor distribution of this radiotracer ex vivo, in association with blood perfusion and known biomarkers of acidity, such as hypoxia, lactate dehydrogenase A, and CAIX. We find that the probe reveals metabolic variations between and within tumors, and discriminates between necrotic and living tumor areas.
Journal Title: Proceedings of the National Academy of Sciences of the United States of America
Volume: 111
Issue: 20
ISSN: 0027-8424
Publisher: National Academy of Sciences  
Date Published: 2014-05-20
Start Page: 7254
End Page: 7259
Language: English
DOI: 10.1073/pnas.1405240111
PROVIDER: scopus
PUBMED: 24785505
PMCID: PMC4034234
DOI/URL:
Notes: Proc. Natl. Acad. Sci. U. S. A. -- Export Date: 2 June 2014 -- CODEN: PNASA -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ronald G Blasberg
    272 Blasberg
  2. Jason A Koutcher
    278 Koutcher
  3. Jason S Lewis
    456 Lewis
  4. Sean Denis Carlin
    83 Carlin
  5. Vadim Divilov
    16 Divilov
  6. Kuntalkumar Sevak
    11 Sevak